BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 18236434)

  • 21. The performance of nanocarriers for transmucosal drug delivery.
    Csaba N; Garcia-Fuentes M; Alonso MJ
    Expert Opin Drug Deliv; 2006 Jul; 3(4):463-78. PubMed ID: 16822222
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hyaluronic acid coated poly(butyl cyanoacrylate) nanoparticles as anticancer drug carriers.
    He M; Zhao Z; Yin L; Tang C; Yin C
    Int J Pharm; 2009 May; 373(1-2):165-73. PubMed ID: 19429302
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Polysaccharide surface modified Fe3O4 nanoparticles for camptothecin loading and release.
    Zhu A; Yuan L; Jin W; Dai S; Wang Q; Xue Z; Qin A
    Acta Biomater; 2009 Jun; 5(5):1489-98. PubMed ID: 19286431
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Polysaccharide-based polyelectrolyte complex nanoparticles from chitosan, heparin, and hyaluronan.
    Boddohi S; Moore N; Johnson PA; Kipper MJ
    Biomacromolecules; 2009 Jun; 10(6):1402-9. PubMed ID: 19371056
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The potential of chitosan in ocular drug delivery.
    Alonso MJ; Sánchez A
    J Pharm Pharmacol; 2003 Nov; 55(11):1451-63. PubMed ID: 14713355
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Challenges to macromolecular drug delivery.
    Juliano R
    Biochem Soc Trans; 2007 Feb; 35(Pt 1):41-3. PubMed ID: 17233596
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mono-N-carboxymethyl chitosan (MCC) and N-trimethyl chitosan (TMC) nanoparticles for non-invasive vaccine delivery.
    Sayin B; Somavarapu S; Li XW; Thanou M; Sesardic D; Alpar HO; Senel S
    Int J Pharm; 2008 Nov; 363(1-2):139-48. PubMed ID: 18662762
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preparation of honokiol-loaded chitosan microparticles via spray-drying method intended for pulmonary delivery.
    Li X; Guo Q; Zheng X; Kong X; Shi S; Chen L; Zhao X; Wei Y; Qian Z
    Drug Deliv; 2009 Apr; 16(3):160-6. PubMed ID: 19514976
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Advances in using chitosan-based nanoparticles for in vitro and in vivo drug and gene delivery.
    Duceppe N; Tabrizian M
    Expert Opin Drug Deliv; 2010 Oct; 7(10):1191-207. PubMed ID: 20836623
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preparation and characterization of laminated thiolated chitosan-based freeze-dried wafers for potential buccal delivery of macromolecules.
    Boateng JS; Ayensu I
    Drug Dev Ind Pharm; 2014 May; 40(5):611-8. PubMed ID: 24506457
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recent advances in chitosan-based nanoparticles for oral delivery of macromolecules.
    Chen MC; Mi FL; Liao ZX; Hsiao CW; Sonaje K; Chung MF; Hsu LW; Sung HW
    Adv Drug Deliv Rev; 2013 Jun; 65(6):865-79. PubMed ID: 23159541
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Self-assembled silk sericin/poloxamer nanoparticles as nanocarriers of hydrophobic and hydrophilic drugs for targeted delivery.
    Mandal BB; Kundu SC
    Nanotechnology; 2009 Sep; 20(35):355101. PubMed ID: 19671963
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chitosan/cyclodextrin nanoparticles can efficiently transfect the airway epithelium in vitro.
    Teijeiro-Osorio D; Remuñán-López C; Alonso MJ
    Eur J Pharm Biopharm; 2009 Feb; 71(2):257-63. PubMed ID: 18955137
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis and characterization of collagen/hyaluronan/chitosan composite sponges for potential biomedical applications.
    Lin YC; Tan FJ; Marra KG; Jan SS; Liu DC
    Acta Biomater; 2009 Sep; 5(7):2591-600. PubMed ID: 19427824
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hyaluronan microgel as a potential carrier for protein sustained delivery by tailoring the crosslink network.
    Luo C; Zhao J; Tu M; Zeng R; Rong J
    Mater Sci Eng C Mater Biol Appl; 2014 Mar; 36():301-8. PubMed ID: 24433916
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Novel mucoadhesive nasal inserts based on chitosan/hyaluronate polyelectrolyte complexes for peptide and protein delivery.
    Luppi B; Bigucci F; Mercolini L; Musenga A; Sorrenti M; Catenacci L; Zecchi V
    J Pharm Pharmacol; 2009 Feb; 61(2):151-7. PubMed ID: 19178761
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development of hyaluronic acid-Fe2O3 hybrid magnetic nanoparticles for targeted delivery of peptides.
    Kumar A; Sahoo B; Montpetit A; Behera S; Lockey RF; Mohapatra SS
    Nanomedicine; 2007 Jun; 3(2):132-7. PubMed ID: 17572355
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fabrication of a nanocarrier system through self-assembly of plasma protein and its tumor targeting.
    Gong G; Zhi F; Wang K; Tang X; Yuan A; Zhao L; Ding D; Hu Y
    Nanotechnology; 2011 Jul; 22(29):295603. PubMed ID: 21673386
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Colloidal carrier integrating biomaterials for oral insulin delivery: Influence of component formulation on physicochemical and biological parameters.
    Woitiski CB; Neufeld RJ; Ribeiro AJ; Veiga F
    Acta Biomater; 2009 Sep; 5(7):2475-84. PubMed ID: 19362890
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Novel hyaluronic acid-chitosan nanoparticles for ocular gene therapy.
    de la Fuente M; Seijo B; Alonso MJ
    Invest Ophthalmol Vis Sci; 2008 May; 49(5):2016-24. PubMed ID: 18436835
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.